Menu Close
Posted in Latest Business Headlines

Actelion boosted by critical drug trials – Financial Times


Bloomberg

Actelion boosted by critical drug trials
Financial Times
By Haig Simonian in Zurich Investors in Actelion breathed a collective sigh of relief on Monday as Europe's biggest biotech group by sales revealed positive test findings for a critical new drug. Basel-based Actelion said a late stage clinical trial
Actelion Says Hypertension Drug Macitentan Met Primary Goals In Pivotal StudyNASDAQ


Actelion to host Conference Call / Audiocast on SERAPHIN Study ResultsReuters
Actelion Lung Drug Meets Main Goal in Pivotal Patient StudyBloomberg
BusinessWeek –MarketWatch
all 29 news articles »

Related Posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.